Skip to main content
Gary Monheit, MD, Dermatology, Birmingham, AL, Callahan Eye Hospital

GaryD.MonheitMD

Dermatology Birmingham, AL

Dermatologic Surgery

Physician

Dr. Monheit is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Monheit's full profile

Already have an account?

Education & Training

  • University of Alabama Medical Center
    University of Alabama Medical CenterResidency, Dermatology, 1974 - 1977
  • University of Southern California/LAC+USC Medical Center
    University of Southern California/LAC+USC Medical CenterInternship, Internal Medicine, 1970 - 1971
  • University of Colorado School of Medicine Anschutz Medical Campus
    University of Colorado School of Medicine Anschutz Medical CampusClass of 1970

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 1973 - 2024
  • AZ State Medical License
    AZ State Medical License 1971 - 2024
  • MA State Medical License
    MA State Medical License 2022 - 2022
  • CA State Medical License
    CA State Medical License 1975 - 2022
  • CO State Medical License
    CO State Medical License 2014 - 2021
  • IL State Medical License
    IL State Medical License 2007 - 2008
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Top MD Consumers Checkbook
  • Fellow (FAAD) American Academy of Dermatology
  • Fellow (FASDS) American Society for Dermatologic Surgery

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Botulinum Toxin: Video Instruction and Live Panel Discussion 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/3/2019

Press Mentions

  • International Peeling Society USA Foundation Announces Inaugural Leadership Team
    International Peeling Society USA Foundation Announces Inaugural Leadership TeamSeptember 13th, 2019
  • OBT-HAECL Versus HYL-HAJU for the Treatment of Moderate-to-Severe Nasolabial Folds: A Phase III, Randomized, Evaluator-Blinded Study
    OBT-HAECL Versus HYL-HAJU for the Treatment of Moderate-to-Severe Nasolabial Folds: A Phase III, Randomized, Evaluator-Blinded StudyJune 1st, 2017

Professional Memberships

Hospital Affiliations